Liver Cancer & Liver Metastases

We provide innovative, evidence-based treatments for people with liver tumors and liver metastases—cancer that has spread to the liver from other organs, such as the colon. Your team of experts includes hepatologists, who specialize in liver diseases, as well as medical oncologists, oncologic surgeons, interventional radiologists, nurses, social workers, and rehabilitation and palliative medicine specialists.

We create a personalized plan and offer modern diagnostic tools and advanced treatments, including specialized procedures performed before surgery to improve liver function. What’s more, we are home to one of the area’s premier centers for liver transplants. Learn more about our treatment for liver cancer and liver metastases at the Liver Tumor Program.

Clinical Trials and Research Studies

Phase 5

A Phase I/II Study of M3814 and Avelumab in Combination with Hypofractionated Radiation in Patients with Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies

Learn More

Phase 1

A Phase 1 First-in Human Multi-Center Open Label Dose-Escalation Study to Determine the Safety Tolerability Pharmacokinetics and RP2D of ABBV-151 as a Single Agent and in Combination with ABBV-181 in Subjects with Locally Advanced or Metastatic Solid Tumors (AbbVie M19-345)

Learn More

Phase 2

A PHASE II RANDOMIZED CONTROLLED TRIAL OF NIVOLUMAB IN COMBINATION WITH BMS-986253 OR CABIRALIZUMAB IN ADVANCED HEPATOCELLULAR CARCINOMA (HCC) PATIENTS

Learn More